- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 828.91K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 828.91K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 828.91K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.3K |
| Capex | Q1 2026 · Mar 31, 2025 | $3.66K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$356.09K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $33.93K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $125.99K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $490.97K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $492.69K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $357.07K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $593.03K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $532.8K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.49M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.26M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.68M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $846.93K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $979.17K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.03M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | $135.61K |
| Net Income | Q1 2026 · Mar 31, 2025 | $60.23K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $151.22K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $42.28K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $599.89K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $443.16K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $385.13K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $159.22K |